News

News

Avilex Pharma is developing best-in-class drugs for diseases in the brain. Find here the latest updates from our progress towards the development of novel therapeutics.

Press Release: Avilex Pharma and Simcere announce strategic partnership

Avilex Pharma and Simcere announce strategic partnership to develop and commercialize novel treatments for acute ischemic stroke in greater china

Read More

Successfully completes phase 1 clinical trial

A compound developed by Danish researchers from the University of Copenhagen could be the key to one of the greatest unsolved challenges in modern medicine.…

Read More

A game-changing treatment for acute ischemic stroke

Acute ischemic stroke is a leading cause of death and disability worldwide with few treatment options available, while subarachnoid haemorrhage is a particular…

Read More